Envestnet Asset Management Inc Haemonetics Corp Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 43,851 shares of HAE stock, worth $3.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,851

Previous 41,712 5.13%

Holding current value

$3.36 Million

Previous $3.45 Million 2.14%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$72.45 - $91.58 $154,970 - $195,889	2,139 Added 5.13%	43,851 $3.52 Million
Q2 2024 Aug 08, 2024	BUY	$81.24 - $97.37 $451,369 - $540,987	5,556 Added 15.37%	41,712 $3.45 Million
Q1 2024 May 13, 2024	BUY	$71.24 - $85.35 $28,353 - $33,969	398 Added 1.11%	36,156 $3.09 Million
Q4 2023 Feb 13, 2024	BUY	$80.59 - $92.61 $165,773 - $190,498	2,057 Added 6.1%	35,758 $3.06 Million
Q3 2023 Nov 13, 2023	BUY	$82.56 - $93.49 $514,431 - $582,536	6,231 Added 22.68%	33,701 $3.02 Million
Q2 2023 Aug 04, 2023	SELL	$80.84 - $89.45 $30.6 Million - $33.9 Million	-379,061 Reduced 93.24%	27,470 $2.34 Million
Q1 2023 May 11, 2023	BUY	$72.75 - $90.6 $27.5 Million - $34.3 Million	378,219 Added 1335.9%	406,531 $33.6 Million
Q4 2022 Feb 07, 2023	BUY	$73.85 - $86.14 $79,610 - $92,858	1,078 Added 3.96%	28,312 $2.23 Million
Q3 2022 Nov 10, 2022	BUY	$63.3 - $78.66 $192,748 - $239,519	3,045 Added 12.59%	27,234 $2.02 Million
Q2 2022 Aug 03, 2022	SELL	$49.27 - $66.08 $25,965 - $34,824	-527 Reduced 2.13%	24,189 $1.58 Million
Q1 2022 May 04, 2022	BUY	$43.77 - $63.22 $412,182 - $595,342	9,417 Added 61.55%	24,716 $1.56 Million
Q4 2021 Feb 04, 2022	SELL	$49.55 - $74.59 $44,099 - $66,385	-890 Reduced 5.5%	15,299 $811,000
Q3 2021 Oct 07, 2021	SELL	$57.6 - $70.59 $171,993 - $210,781	-2,986 Reduced 15.57%	16,189 $1.14 Million
Q2 2021 Aug 04, 2021	SELL	$51.81 - $118.56 $590,478 - $1.35 Million	-11,397 Reduced 37.28%	19,175 $1.28 Million
Q1 2021 May 04, 2021	BUY	$111.01 - $139.48 $83,035 - $104,331	748 Added 2.51%	30,572 $3.39 Million
Q4 2020 Feb 02, 2021	BUY	$88.75 - $119.95 $492,118 - $665,122	5,545 Added 22.84%	29,824 $3.54 Million
Q3 2020 Oct 09, 2020	BUY	$75.65 - $93.58 $615,791 - $761,741	8,140 Added 50.44%	24,279 $2.12 Million
Q2 2020 Jul 08, 2020	BUY	$84.96 - $118.91 $227,267 - $318,084	2,675 Added 19.87%	16,139 $1.45 Million
Q1 2020 Apr 23, 2020	BUY	$74.34 - $121.82 $249,708 - $409,193	3,359 Added 33.24%	13,464 $1.34 Million
Q4 2019 Feb 11, 2020	BUY	$114.37 - $129.46 $58,443 - $66,154	511 Added 5.33%	10,105 $1.16 Million
Q3 2019 Oct 17, 2019	BUY	$117.16 - $138.52 $529,680 - $626,248	4,521 Added 89.12%	9,594 $1.21 Million
Q2 2019 Aug 02, 2019	BUY	$81.74 - $120.34 $99,804 - $146,935	1,221 Added 31.7%	5,073 $610,000
Q1 2019 May 10, 2019	SELL	$83.25 - $102.12 $869,213 - $1.07 Million	-10,441 Reduced 73.05%	3,852 $337,000
Q4 2018 Feb 13, 2019	BUY	$90.66 - $116.63 $1.3 Million - $1.67 Million	14,293 New	14,293 $1.43 Million
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $1.62 Million - $2.07 Million	-18,049 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$71.53 - $95.75 $565,516 - $756,999	-7,906 Reduced 30.46%	18,049 $1.62 Million
Q1 2018 May 09, 2018	SELL	$60.72 - $74.41 $43,111 - $52,831	-710 Reduced 2.66%	25,955 $1.9 Million
Q4 2017 Feb 20, 2018	BUY	$44.96 - $58.99 $4,181 - $5,486	93 Added 0.35%	26,665 $1.55 Million
Q3 2017 Nov 13, 2017	SELL	$40.38 - $44.87 $103,695 - $115,226	-2,568 Reduced 8.81%	26,572 $1.19 Million
Q2 2017 Aug 14, 2017	BUY	N/A	29,140	29,140 $1.15 Million

Others Institutions Holding HAE

# of Institutions

332

Shares Held

53.8M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.93B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Haemonetics Corp Transaction History